Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksConduit Hldg Regulatory News (CRE)

Share Price Information for Conduit Hldg (CRE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 502.00
Bid: 500.00
Ask: 502.00
Change: 7.00 (1.41%)
Spread: 2.00 (0.40%)
Open: 492.00
High: 502.00
Low: 492.00
Prev. Close: 495.00
CRE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Results

30 Nov 2010 07:00

RNS Number : 0109X
Creston PLC
30 November 2010
 



 

30 November 2010

Creston plc

 

Interim Results for the Six Months Ended 30 September 2010

 

Revenue growth of 9 per cent driven by success of new business and start-ups

 

Financial Highlights

 

·; Revenue from continuing operations up 9 per cent to £32.0 million (H1 2010: £29.5 million)

·; Headline(1) PBIT(2) of £4.4 million (H1 2010: £5.1 million), reflecting investment in start-ups and staffing for increased revenue

·; Reported PBIT of £4.4 million (H1 2010: £0.6 million)

·; Net cash of £0.2 million (March 2010 net debt: £24.9 million)

·; Reinstatement of interim dividend of 0.75p per share (H1 2010: nil)

 

Operational Highlights

·; Disposal of advertising business, DLKW Group, for a cash consideration of £28.0 million

·; Digital and online now represent 41 per cent of revenue (H1 2010: 31 per cent)

·; Formation of Intensity Digital Ltd to deliver integrated digital communications in healthcare

·; Annualised net new business wins of £6 million in revenue (H1 2010: £4 million) include Astellas, BP Castrol, CA Technologies, Guinness digital, Intercontinental Hotel Group, Pfizer, Rolls Royce, Sony Europe, Twinings, ViiV Healthcare and a major international financial services company

·; Announced today: Proposed acquisition of the trade and assets of Cooney/Waters, a leading New York based healthcare public relations business, and its subsidiary, Alembic Health Communications, for an initial cash consideration of $9.4 million (£5.9 million)

 

Financial Results for Continuing Group(3)

Headline results

Reported results

H1 2011

£ million

H1 2010

£ million

H1 2011

£ million

H1 2010

£ million

Revenue

32.0

29.5

32.0

29.5

PBIT

4.4

5.1

4.4

0.6

PBT

4.2

4.8

4.2

0.2

Diluted EPS (pence)

5.06

6.49

5.02

-0.92

Dividend per share

(pence)

 

0.75

 

-

 

0.75

 

-

 

(1) Headline results reflect the underlying performance of the Group and excludes deemed remuneration charges from the Reported results. A full reconciliation is presented in Note 4 to this Interim Report.

(2) Profit before Interest and Tax (PBIT) is defined as profit before finance income, finance costs, income from financial assets and taxation.

(3) The Continuing Group excludes the discontinued operation, being DLKW (see note 7 to this Interim Report).

 

Commenting on the results, Don Elgie, Chief Executive of Creston plc, said:

 

"The nine per cent increase in first half revenue from continuing operations is testament to the abilities of our people to rise to the challenges of a weak economy. We have had a very active first half with a notable increase in new business opportunities and pitch successes, and we are encouraged by the gradual return of marketing budgets across our client base.

 

"Our commitment to investing in start-ups and acquisitions is unwavering and we continue to enhance the propositions of our three divisions of Insight, Communications and Health, with a focus on the continued development of digital capabilities and international growth. We are confident that following this period of investment our margins will return to historic levels, and we believe we are well positioned for the period ahead."

 

 There will be a presentation for analysts at 8.30am at the offices of Investec Securities. Please contact Creston on 020 7930 9757 for details.

  

For further information, contact:

 

Creston plc Tel: 020 7930 9757

Don Elgie, Chief Executive

Barrie Brien, COO & CFO

Sarah Macleod, Communications Director

 

www.creston.com 

 

 Chief Executive's Statement

 

In the first half of the year we sold our traditional advertising agency, DLKW, for £28.0 million, formed a new digital healthcare company, Intensity Digital Ltd, and today announced the acquisition of Cooney/Waters, a leading US healthcare PR agency. It has been an active period and as a result we believe the Group is better positioned than ever before to deliver clients the insight and communications that they require in today's digital age.

 

Looking at our established businesses, the past six months can be characterised by a general stabilisation of existing client budgets across much of the Group together with an increase in new business opportunities. Particularly strong demand for the services of EMO, our local marketing agency, and of Fever and Nelson Bostock in consumer and technology PR respectively, indicate a continuing trend in marketing spend towards services more directly engaging with consumers and the public.

 

Together, these factors have contributed to a very strong 9 per cent increase in revenue for the period on a continuing group basis. This compares favourably to the previous year's first half, where there was a 3 per cent decline. Revenue from both digital and international communications has grown at 20 per cent and 6 per cent respectively, and further development in these areas remains a key goal for Creston.

 

As a natural consequence of the large increase in revenue and in line with the current market tends, we have experienced a short-term increase in staff costs. This, together with our continued investment in new initiatives, services and staff training, has impacted headline profit in the period. Going forward, the reduction in operating profit margin will be reversed as we focus on improving the profit conversion and margin on the increased revenue and target a return to our historic margins in the medium term.

 

Our strategy to drive growth is centred on our investment in start-ups and acquisitions, while underpinning this with innovation and collaboration across our divisions of Insight, Communications and Health.

 

Investing in start-ups is about delivering rapid responses to the increasing demand for innovation and digital capabilities across the marketing spectrum. Supporting those start-ups, our Centres of Excellence forge collaboration within and across our three divisions, thereby delivering efficiencies to clients while simultaneously providing them with new and effective solutions. I believe our unique offering gives clients an advantage in their marketing programmes which in turn underpins our new business success. The annualised value of our net new business wins in the first half of the financial year (£6 million) compared to the same period last year (£4 million), demonstrates the continued strength of our offering.

 

One of the strategic reasons for disposing of DLKW was to accelerate acquisitions and investment in areas that offer greater opportunities for growth, with a focus on the expansion of our companies' existing propositions, either internationally or by adding complementary services.

 

In the case of our Health division, which has continued to grow throughout the downturn, we believe a physical presence in the world's largest pharmaceutical market of the USA is essential to its continued success and we are delighted to announce today the proposed acquisition of the trade and assets of both Cooney/Waters, a New York based specialist healthcare public relations firm, and its subsidiary, Alembic Health Communications (together the "Cooney/Waters Businesses"), which is subject to shareholder approval. Cooney/Waters has a record of delivering award-winning campaigns to an international client base and a reputation for delivering expert advice with high levels of service. In April 2010, it was named Healthcare Agency of the Year by The Holmes Report¸ a leading communications industry publication. It has a strong cultural and strategic fit with our UK healthcare PR agency, Red Door Communications, and the two companies have a history of working together on numerous joint clients via their international affiliate network, the Health Collective.

 

We believe that bringing the Cooney/Waters Businesses into the Creston Health division will provide the necessary scale and geographical reach required to compete more effectively for larger global briefs in healthcare PR, as well as increasing the synergy potential for our other Health division companies.

 

New Business

 

There have been some notable successes during the period securing £6 million, on an annualised basis, of net new business revenue from new and existing clients.

 

Insight division:

·; ICM won a major contract from Sainsbury's at the end of the period, which will benefit the second half; and

·; Marketing Sciences won new global briefs from Twinings and BP Castrol.

 

Communications division:

·; EMO won a global brief for Rolls Royce in addition to securing a new three-year contract with the BMW, MINI and Motorrad brands, and winning a brief from Intercontinental Hotel Group;

·; Consumer PR start-up, Fever, won a global brief for a major international financial services company;

·; Nelson Bostock won CA Technologies, the leading IT management software and solutions company;

·; The Real Adventure was appointed as digital and direct agency for Twinings Tea; and

·; TMW won campaigns from Abbott, Sony Professional Services, Pfizer and Saudi Clusters. In addition, TMW were, in November, awarded Guinness's digital relationship marketing programme as well as securing a place on a newly created roster for all below the line activity including Shopper Marketing for Guinness, Gordon's, Baileys, Pimms, Bells and Bushmills.

 

Health division:

·; PAN benefitted from a strong flow of new projects from existing clients including three new brands from Astellas, and new brands from Takeda and GSK, while also adding new client Kowa to its roster;

·; Red Door Communications won significant new projects from existing clients such as ViiV Healthcare and Astellas, while adding Takeda and Panasonic to its roster; and

·; ROCK medical communications continued its strong growth winning new accounts with UCB, ViiV Healthcare, NAPP and GSK.

 

Financial Review

 

In the first half of the financial year we announced the sale of DLKW, the Group's advertising agency for a consideration of £28.0 million. The Group recognised a loss on disposal of £3.5 million (see note 7 to this Interim Report). We have reported DLKW as a discontinued operation and the results discussed below are presented on a continuing group basis.

 

Revenue increased by 9 per cent to £32.0 million (H1 2010: £29.5 million) during the first half of the financial year, owing to an increase in the number of new business opportunities and pitch successes.

 

Headline PBIT decreased by 12 per cent to £4.4 million (H1 2010: £5.1 million). The operating margin declined in the first half of the year for a number of reasons, including the following:

 

(i) During the period, the rapid growth in revenue has required additional resource, resulting in a short-term increase in recruitment fees and temporary staff costs;

(ii) The start-ups launched over the last 12-18 months have contributed to our revenue growth, however, they are yet to operate at the higher levels of margin achieved elsewhere in the Group;

(iii) The Group has made significant investments in developing and training senior operating company management. Although costly (in terms of time and money), this will enhance the strategy, performance and synergy of the Group; and

(iv) The Group suffered a loss of £0.2 million as a result of the adverse movement in the euro to sterling exchange rate. There was no significant impact on foreign exchange in the prior period. On 1 October 2010 the Group entered into a participating forward contract maturing on 31 March 2011, which will help to mitigate any future exposure to foreign exchange movements.

 

Excluding the foreign exchange loss, operating company Headline PBIT (i.e. Headline PBIT before head office costs) decreased by only 5 per cent to £5.9 million (H1 2010: £6.3 million).

 

Reported PBIT increased to £4.4 million (H1 2010: £0.6 million). In H1 2010 there was a £3.8 million charge relating to the write-off of CML goodwill following its closure. The Headline adjustments for H1 2011 is a non-cash charge for deemed remuneration (£38k).

 

Headline PBT decreased by 12 per cent to £4.2 million (H1 2010: £4.8 million), a smaller decrease than the Headline PBIT reduction due to a decline in interest expense resulting from the Group being effectively debt free from 14 July 2010. Reported PBT increased by £4.0 million to £4.2 million.

 

Headline diluted EPS decreased by 22 per cent to 5.06 pence (H1 2010: 6.49 pence) per share as a result of lower Headline PBT and a higher effective tax rate than the prior year. The prior year included a release of tax provisions related to CML goodwill, which decreased the effective tax rate to 24 per cent. Reported diluted EPS increased to 5.02 pence (H1 2010: loss of 0.92 pence) per share.

 

Divisional Review

 

Insight

 

H1 2011

£ million

H1 2010

£ million

Change

%

Revenue

7.7

7.8

-2%

Headline PBIT

2.2

2.4

-8%

Reported PBIT

2.2

(1.7)

-

Headline PBIT Margin (%)

28%

30%

 

During the first half of the year the Insight division saw revenue decline by 2 per cent; a resilient performance against a backdrop of social and government budget cuts, which affected both ICM and Marketing Sciences.

 

Inspired, a new brand launched earlier this year, was set up in response to growing client demand for consumer-focussed insight. Offering joint qualitative and quantitative research capabilities and drawing upon expertise from across our Insight companies, the brand is already generating an income stream from existing clients.

 

In addition, a new senior management team was recruited at ICM to drive business development and initiatives in digital and online research. The four external hires, led by former Kantar executive Justin Sampson as ICM Chairman, are experienced industry executives who will provide continued impetus and direction to ICM. This has had a short-term affect on the division's profit margin due to the associated recruitment costs.

 

Communications

 

H1 2011

£ million

H1 2010

£ million

Change

%

Revenue

19.8

17.4

+14%

Headline PBIT pre FX

2.5

2.5

+1%

Foreign exchange

(0.2)

0.0

-

Headline PBIT

2.3

 2.5

-7%

Reported PBIT

 2.3

 2.2

+8%

Headline PBIT Margin (%)

 12%

14%

 

The division experienced a very busy first half with revenue, on a continuing group basis, increasing by 14 per cent. This growth was due to particularly strong performances from EMO, Fever, and Nelson Bostock, with a general increase in new business across the whole division.

 

Headline PBIT before net foreign exchange losses showed an increase of 1 per cent to £2.5 million (H1 2010: £2.5 million). After the foreign exchange losses of £0.2 million Headline PBIT decreased by 7 per cent to £2.3 million (H1 2010: £2.5 million).

 

The Headline PBIT margin has suffered as a consequence of the increased staffing requirements to service the very high revenue growth. These issues have now been addressed and the division is focused on improving its profit conversion and margin on the increased revenue.

 

Health

 

H1 2011

£ million

H1 2010

£ million

Change

%

Revenue

4.5

4.2

+6%

Headline PBIT

1.2

1.4

-12%

Reported PBIT

1.2

1.4

-12%

Headline PBIT Margin (%)

27%

33%

 

The Health division continued to perform well, reporting an increase in revenue of 6 per cent in the period, slightly ahead of the growth rate in the full year 2010 and the comparative half year period. The encouraging revenue performance demonstrates the resilience of the sector against the vagaries of the economy.

 

The margin decline in the first half of the year has been caused by the investment in an over-the-counter consumer advertising proposition from PAN. Demonstrating the benefits of this investment, the team has already achieved a project win from GSK's Oilatum and we are confident of its growing success.

 

The formation of Intensity Digital Ltd in September 2010 is a response to a shift in emphasis of pharmaceutical marketing budgets towards integrated digital communications in the sector. Given the high level of specialist clinical and regulatory knowledge required to compete in this space, Intensity Digital is well placed to benefit from the growing trend in communicating directly via digital mediums to the health specialists. This offer is complementary to the tmwdigitalhealth proposition, which focuses on large website builds, database and ECRM management.

 

In addition to collaborating on an increasing number of clients' campaigns, the Health division continues to work closely with the Insight and Communications divisions.

 

Cash Management and Net Debt

 

The Group paid down its debt using the net proceeds from the disposal of DLKW of £27.4m. Of the £28.0 million received from the disposal of DLKW, £0.6 million was spent on related advisor fees. £50k of net assets, of which £1.3 million was cash, remained on the DLKW balance sheet and was disposed of as part of the transaction. £3.1 million of loan notes relating to previous acquisitions were paid during the period with a nominal amount of £30k of loan notes outstanding on the Group balance sheet.

 

As expected, cash conversion (ratio of operating cash flow to Headline EBITDA(4)) was low at 36 per cent (H1 2010: 72 per cent). This decline was because in the 2010 financial year the conversion rate of 113 per cent was high and therefore the 2010 year ended with a low working capital position. In the 2011 financial year this has now returned to a more normal level.

 

The Group has committed bank facilities of £25.0 million available until March 2012, and on completion of the proposed acquisition £5 million will be available until March 2013. As at 30 September 2010 this facility was undrawn.

 

Taxation

 

The Headline and Reported tax charge on a continuing operations basis is in line with the current statutory rate of 28%.

 

Dividend

 

With the Group's return to revenue growth, a strong balance sheet and the current positive momentum in the business, the Board believes it is appropriate to reinstate the interim dividend. Therefore, an interim dividend per share of 0.75 pence (H1 2010: nil) will be paid on 10 January 2011 to shareholders on the register at 10 December 2010.

 

Outlook

 

After a particularly strong revenue performance in the first half of the year, there is positive momentum across the Group and the new business pipeline remains active. During the second half, anticipated new business wins are expected to offset tightening public sector research and marketing budgets which, although minimal, will have some impact on the Group.

 

Our second half is traditionally our strongest period. With continuing new business successes, the upside from investments in the first half and the proposed acquisition of the Cooney/Waters Businesses, we believe we are well positioned for the period ahead.

 

Don Elgie

Chief Executive

 

(4) Earnings before finance income, finance costs, income from financial assets, taxation, depreciation and amortisation (EBITDA). 

 

 

 

UNAUDITED CONSOLIDATED INCOME STATEMENT

for the six months ended 30 September 2010

 

Note

Six months ended

30 September 2010

£'000

Six months ended

30 September 2009

£'000

Year ended

31 March

2010

£'000

Continuing operations:

Turnover (billings)

45,887

45,142

93,673

 

Revenue

5

32,011

29,494

61,259

Operating costs

(27,566)

(24,415)

(50,447)

 

Headline profit before finance income, finance costs, income from financial assets and taxation

 

 

 

4

 

 

 

4,445

 

 

 

5,079

 

 

 

10,812

Headline items

4

(38)

(4,473)

(4,887)

Profit before finance income, finance costs, income from financial assets and taxation

 

 

4

 

 

4,407

 

 

606

 

 

5,925

Finance income

1

1

6

Finance costs

(212)

(455)

(1,080)

Income from financial assets

-

-

195

 

Profit before taxation

4

 

4,196

152

5,046

Taxation

6

(1,170)

(677)

(2,128)

 

Profit/(loss) for the period from continuing operations

 

4

 

3,026

 

(525)

 

2,918

 

Discontinued operations:

7

(Loss)/profit for the period from discontinued operations

 

(3,159)

 

960

 

2,215

(Loss)/profit for the period

(133)

435

5,133

Basic earnings/(loss) per share (pence):

8

From continuing operations

5.02

(0.92)

4.98

From discontinued operations

(5.24)

1.68

3.77

(0.22)

0.76

8.75

Diluted earnings/(loss) per share (pence):

8

From continuing operations

5.02

(0.92)

4.97

From discontinued operations

(5.24)

1.68

3.77

(0.22)

0.76

8.74

 

 

UNAUDITED CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME

for the six months ended 30 September 2010

 

Note

Six months ended

30 September 2010

£'000

Six months ended

30 September 2009

£'000

Year ended

31 March

2010

 

£'000

(Loss)/profit for the period

(133)

435

5,133

 

Other comprehensive income/(expense)

 

 

Cash flow hedge:

Fair value gain/(loss) in period

 

11

 

188

 

(287)

 

(188)

Tax effect of fair value (gain)/loss

 

(53)

 

80

 

53

Other comprehensive income/(expense) for the period, net of tax

 

 

135

 

 

(207)

 

 

(135)

 

 

Total comprehensive income for the period

 

2

 

228

 

4,998

 

UNAUDITED CONSOLIDATED BALANCE SHEET

as at 30 September 2010

 

Note

As at

30 September

2010

£'000

As at

30 September

2009

£'000

As at

31 March

2010

£'000

Non-current assets

Intangible assets

Goodwill

10

88,548

119,081

119,081

Other

10

1,148

1,619

1,551

Property, plant and equipment

10

1,754

2,401

2,065

Financial assets - available for sale

550

550

550

Deferred tax assets

533

889

766

92,533

124,540

124,013

Current assets

Inventories and work in progress

1,842

2,522

2,937

Trade and other receivables

22,914

29,175

32,346

Cash and short term deposits

13

232

16

2,778

24,988

31,713

38,061

Current liabilities

Trade and other payables

(19,503)

(28,663)

(35,884)

Corporation tax payable

(2,593)

(1,458)

(2,398)

Obligations under finance leases

13

(7)

(4)

(8)

Bank overdraft, loans and loan notes

13

(30)

(24,695)

(27,687)

Derivative financial instrument

11

-

(287)

(135)

(22,133)

(55,107)

(66,112)

Net current assets/(liabilities)

2,855

(23,394)

(28,051)

Total assets less current liabilities

95,388

101,146

95,962

Non-current liabilities

Bank loans and loan notes

13

-

(10,000)

-

Obligations under finance leases

13

(8)

-

(8)

(8)

(10,000)

(8)

Net assets

95,380

91,146

95,954

Equity

Called up share capital

6,134

6,134

6,134

Share premium account

35,943

35,943

35,943

Own shares

(779)

(851)

(801)

Shares to be issued

1,463

1,643

1,461

Other reserves

31,357

31,357

31,357

Retained earnings

21,262

16,920

21,860

Total equity

95,380

91,146

95,954

UNAUDITED STATEMENT OF CHANGES IN EQUITY

Six months ended 30 September 2010

 

Share capital

 

£'000

Share premium

 

£'000

Own shares

 

£'000

Shares to be issued

£'000

Other reserves

 

£'000

Retained earnings

 

£'000

Total

 

 

£'000

Changes in equity for the period

At 1 April 2010

6,134

35,943

(801)

1,461

31,357

21,860

95,954

Loss for the period

-

-

-

-

-

(133)

(133)

Other comprehensive income:

Fair value gain on financial liability

 

188

 

188

-

-

-

-

-

Tax effect of fair value gain

-

-

-

-

-

(53)

(53)

Total comprehensive income for the period

 

-

 

-

 

-

 

-

 

-

 

2

 

2

Credit for share-based incentive schemes

 

-

 

-

 

-

 

30

 

-

 

-

 

30

Exercise of share award

-

-

22

(28)

-

-

(6)

Gain on treasury scheme/ employee benefit trust

 

-

 

-

 

-

 

-

 

-

 

6

 

6

Fair value adjustment of own shares issued

 

-

 

-

 

-

 

-

 

-

 

(3)

 

(3)

Dividends (note 9)

-

-

-

-

-

(603)

(603)

At 30 September 2010

6,134

35,943

(779)

1,463

31,357

21,262

95,380

 

Six months ended 30 September 2009

 

 

 

Share capital

 

£'000

Share premium

 

£'000

Own shares

 

£'000

Shares to be issued

£'000

Other reserves

 

£'000

Retained earnings

 

£'000

Total

 

 

£'000

Changes in equity for the period

At 1 April 2009

5,576

33,345

(1,054)

2,706

31,357

15,938

87,868

Profit for the period

-

-

-

-

-

435

435

Other comprehensive income:

Fair value loss on financial liability

 

(287)

 

(287)

-

-

-

-

-

Tax effect of fair value loss

 

-

 

-

 

-

 

-

 

-

 

80

 

80

Total comprehensive income for the period

 

-

 

-

 

-

 

-

 

-

 

228

 

228

Debit for share-based incentive schemes

 

-

-

 

-

 

(123)

 

-

 

-

 

(123)

Exercise of share award

-

-

203

(940)

-

-

(737)

Loss on treasury scheme/ employee benefit trust

-

-

-

-

-

(11)

(11)

Gain on treasury scheme/ employee benefit trust

-

-

-

-

-

177

177

Fair value adjustment of own shares issued

 

-

 

-

 

-

 

-

 

-

 

588

 

588

Proceeds from shares issued

 

558

 

2,788

 

-

 

-

 

-

 

-

 

3,346

Costs associated with shares issued

 

-

 

(190)

 

-

 

-

 

-

 

-

 

(190)

At 30 September 2009

6,134

35,943

(851)

1,643

31,357

16,920

91,146

 

 

Year ended 31 March 2010

 

 

Share capital

 

£'000

Share premium

 

£'000

Own shares

 

£'000

Shares to be issued

£'000

Other reserves

 

£'000

Retained earnings

 

£'000

Total

 

 

£'000

Changes in equity for the year

At 1 April 2009

5,576

33,345

(1,054)

2,706

31,357

15,938

87,868

Profit for the year

-

-

-

-

-

5,133

5,133

Other comprehensive income:

Fair value loss on financial liability

 

(188)

 

(188)

-

-

-

-

-

Tax effect of fair value loss

 

-

 

-

 

-

 

-

 

-

 

53

 

53

Total comprehensive income for the year

 

-

 

-

 

-

 

-

 

-

 

4,998

 

4,998

Credit for share-based incentive schemes

 

-

-

 

-

 

11

 

-

 

-

 

11

Exercise of share award

-

-

253

(1,202)

-

-

(949)

Loss on treasury scheme/ employee benefit trust

-

-

-

-

-

(11)

(11)

Gain on treasury scheme/ employee benefit trust

-

-

-

-

-

185

185

Fair value adjustment of own shares issued

 

-

 

-

 

-

 

-

 

-

 

696

 

696

Proceeds from shares issued

 

558

 

2,788

 

-

 

-

 

-

 

-

 

3,346

Costs associated with shares issued

 

-

 

(190)

 

-

 

-

 

-

 

-

 

(190)

Transfer of lapsed options

 

-

 

-

 

-

 

(54)

 

-

 

54

 

-

At 31 March 2010

6,134

35,943

(801)

1,461

31,357

21,860

95,954

 

 

UNAUDITED CONSOLIDATED STATEMENT OF CASHFLOWS

for the six months ended 30 September 2010

 

Note

Six months

ended

30 September

2010

£'000

Six months

ended

30 September

2009

£'000

Year

ended

31 March

2010

£'000

 

Operating cash flow

12

1,869

4,117

13,686

Tax paid

(261)

(1,063)

(1,812)

Cash (outflow)/inflow from discontinued operating activities

 

(1,058)

 

1,567

 

3,568

Net cash inflow from operating activities

 

550

 

4,621

 

15,442

Investing activities

Finance income

1

1

6

Income from financial assets

-

-

195

Purchase of subsidiary undertakings

(3,057)

(3,150)

(20,058)

Purchase of property, plant and

equipment

 

10

 

(532)

 

(558)

 

(848)

Proceeds from sale of property, plant and equipment

 

-

 

16

 

12

Purchase of intangible assets

10

(81)

(123)

(227)

Decrease in restricted cash deposits

-

8

22

Net proceeds from disposal of subsidiary

 

27,374

 

-

 

-

Cash outflow from discontinued investing activities

 

(1,376)

 

(96)

 

(155)

Net cash inflow/(outflow) from investing activities

 

22,329

 

(3,902)

 

(21,053)

Financing activities

Net proceeds from issuance of ordinary shares

-

3,156

3,156

Finance costs

(221)

(275)

(766)

Net (decrease)/increase in borrowings

(24,600)

(6,400)

3,200

Dividends paid

(603)

-

-

Capital element of finance lease payments

 

(1)

 

(4)

 

(7)

Cash flows from discontinued financing activities

 

-

 

-

 

-

Net cash (outflow)/inflow from financing activities

 

(25,425)

 

(3,523)

 

5,583

(Decrease) in cash and cash equivalents

(2,546)

(2,804)

(28)

Cash and cash equivalents at start of period

 

2,778

 

2,806

 

2,806

Cash and cash equivalents at end of period

 

13

 

232

 

2

 

2,778

 

NOTES TO THE INTERIM REPORT

for the six months ended 30 September 2010

 

1. Presentation of financial information

 

The financial information contained in this Interim Report does not constitute statutory accounts within the meaning of Section 434 of the Companies Act 2006.

 

Statutory accounts for the year ended 31 March 2010 were approved by the Board of directors on 12 July 2010 and delivered to the Registrar of Companies. The report of the auditors, by PricewaterhouseCoopers LLP on those accounts was unqualified, did not contain an emphasis of matter paragraph and did not contain any statement under Section 448 of the Companies Act 2006.

 

The Interim Report has not been audited or reviewed by the Group's auditors.

 

2. Basis of Preparation

 

The Interim Report of Creston plc for the six months ended 30 September 2010 has been prepared in accordance with the Disclosure and Transparency Rules of the Financial Services Authority and with IAS 34, "Interim financial reporting" as adopted by the European Union.

 

The accounting policies applied in the preparation of the annual financial statements are based on the European Union adopted International Financial Reporting Standards (IFRS) and IFRIC interpretations that are applicable at this time.

 

The condensed interim consolidated financial information should be read in conjunction with the annual financial statements for the year ended 31 March 2010 which have been prepared in accordance with IFRS as adopted by the European Union.

3. Accounting policies

 

The interim consolidated financial statements of Creston plc for the six months ended 30 September 2010 have been prepared in accordance with the accounting policies contained in the Group's Annual Report and Accounts 2010 and the policies as described in Note 2 above.

 

The following new standards, amendments to standards or interpretations are mandatory for the first time for financial years beginning 1 April 2010, but are not currently relevant for the group and have had no effect on the reported results:

 

IFRS 3 (revised), 'Business combinations';

 

IAS 27 (amendment), 'Consolidated and separate financial statements';

 

IFRIC 17, 'Distributions of non-cash assets to owners', effective for annual periods beginning on or after 1 July 2009; and

 

Improvements to International Financial Reporting Standards 2009 were issued in April 2009. The effective dates vary standard by standard but most are effective 1 January 2010.

 

The following new standards, amendments to standards or interpretations have been issued, but are not effective for the financial year beginning 1 April 2010 and have not been early adopted:

 

IFRS 9, 'Financial instruments', issued in December 2009. This addresses the classification and measurement of financial assets and is likely to affect the Group's accounting for its financial assets. The standard is not a mandatory requirement until 1 January 2013 but is available for early adoption; and

 

Revised IAS 24, 'Related party disclosures', issued in November 2009. This supersedes IAS 24, 'Related party disclosures', issued in 2003. The revised IAS 24 is required to be applied from 1 January 2011. Earlier application, in whole or in part, is permitted.

  

4. Reconciliation of Headline profit to Reported profit

 

In order to enable a better understanding of the underlying trading of the Group, the Directors refer to Headline PBIT, PBT and PAT which eliminate non-recurring charges from the Reported figures. These break down into two parts:

 

(i) Certain accounting policies that have a material impact and introduce volatility to the Reported figures. These are acquisition-related charges deemed as remuneration arising on payments made by Creston to non-shareholding employees in respect of the consideration on the business acquisitions. In the financial year ending 31 March 2010 there were also notional finance costs relating to the deferred consideration.

 

(ii) Exceptional non-recurring operating charges in the financial year 2010 were restructuring costs, closure costs relating to CML and MSTS and the write-off of goodwill in respect of CML. There were no such costs in the first half of this financial year.

 

 

Six months ended 30 September 2010

PBIT

PBT

PAT

£'000

£'000

£'000

Headline

4,445

4,234

3,053

Future acquisition payments to employees deemed as remuneration

(38)

(38)

(38)

Taxation impact

11

Reported

4,407

4,196

3,026

 

Headline Basic and Diluted EPS (pence)

5.06

Reported Basic and Diluted EPS (pence)

5.02

Six months ended 30 September 2009

PBIT

PBT

PAT

£'000

£'000

£'000

Headline

5,079

4,814

3,692

Restructuring costs

(433)

(433)

(433)

Goodwill write-off

(3,786)

(3,786)

(3,786)

Future acquisition payments to employees deemed as remuneration

(254)

(254)

(254)

Notional finance costs on future deferred consideration

-

(189)

(189)

Taxation impact

445

Reported

606

152

(525)

Headline Basic and Diluted EPS (pence)

6.49

Reported Basic and Diluted EPS (pence)

(0.92)

 

 

Year ended 31 March 2010

PBIT

PBT

PAT

£'000

£'000

£'000

Headline

10,812

10,337

7,912

Restructuring costs

(584)

(584)

(584)

Goodwill write-off

(3,786)

(3,786)

(3,786)

Future acquisition payments to employees deemed as remuneration

(517)

(517)

(517)

Notional finance costs on future deferred consideration

-

(404)

(404)

Taxation impact

297

Reported

5,925

5,046

2,918

Headline Basic EPS (pence)

13.47

Headline Diluted EPS (pence)

13.46

Reported Basic EPS (pence)

4.98

Reported Diluted EPS (pence)

4.97

 

5. Segmental analysis

 

The chief operating decision-maker has been identified as the Board of Directors ('the Board') who make the strategic decisions. The Board has determined the operating segments in a manner consistent with the internal reporting provided to the Board. The Board considers the business from a divisional perspective, that being Insight, Communications and Health.

 

The principal activities of the three divisions are as follows:

 

Insight

The Insight division performs a complete range of market research services on behalf of its clients, through both qualitative and quantitative means using the mediums of face-to-face, telephone and online techniques.

 

Communications

The Communications division offers clients an integrated approach to their marketing and communication strategy, offering a range of services which include brand strategy, channel marketing, relationship marketing (CRM), digital marketing, direct marketing, promotional marketing and public relations.

 

Health

The Health division provides an integrated communications solution to the healthcare and pharmaceuticals sectors and offers services which include advertising, direct marketing, digital marketing, public relations, issue management, market research and medical education.

 

The Board assesses the performance of the operating segments based on a measure of revenue and Headline PBIT. This measurement basis excludes the effects of non-recurring charges from the operating segments, such as restructuring costs, write-off of goodwill, notional interest and deemed remuneration charges.

 

Accounting policies are consistent across the reportable segments.

 

All significant assets and liabilities are located within the UK. The Board does not review the assets and liabilities of the Group on a divisional basis and as such has not segmented the assets and liabilities of the Group.

 

Other information provided to the Board of Directors is measured in a manner consistent with that in the financial statements.

 

The divisional analysis below excludes the results of DLKW (which were reported as part of the Communications division) as it has been classed as a discontinued operation. The prior period numbers have also been reported on a continuing Group basis.

 

Divisional segmentation

 

Turnover, revenue, Headline and Reported profit before financial income, finance costs, income from financial assets and taxation (PBIT), and profit before tax attributable to group activities are shown below.

 

Six months ended

Insight

Communications

Health

Head office

Group

30 September 2010

£'000

£'000

£'000

£'000

£'000

Turnover (billings)

14,114

26,249

5,524

-

45,887

Revenue

7,705

19,841

4,465

-

32,011

Headline PBIT

2,177

2,340

1,217

(1,289)

4,445

Future acquisition payments to employees deemed as remuneration

 

 

-

 

 

-

 

 

-

 

 

(38)

 

 

(38)

Reported PBIT

2,177

2,340

1,217

(1,327)

4,407

Finance income

-

-

-

1

1

Finance costs

-

-

-

(212)

(212)

Profit before taxation

2,177

2,340

1,217

(1,538)

4,196

Taxation

 

(1,170)

Profit for the period

 

3,026

 

 

 

Six months ended

Insight

Communications

Health

Head office

Group

30 September 2009

£'000

£'000

£'000

£'000

£'000

Turnover (billings)

13,749

26,494

4,899

-

45,142

Revenue

7,845

17,418

4,231

-

29,494

Headline PBIT

2,373

2,507

1,390

(1,191)

5,079

Restructuring costs

(296)

(137)

-

-

(433)

Goodwill write-off

(3,786)

-

-

-

(3,786)

Future acquisition payments to employees deemed as remuneration

 

 

(36)

 

 

(213)

 

 

(5)

 

 

-

 

 

(254)

Reported PBIT

(1,745)

2,157

1,385

(1,191)

606

Finance income

-

-

-

1

1

Finance costs

-

-

-

(266)

(266)

Notional interest

(89)

(97)

(3)

-

(189)

Profit before taxation

(1,834)

2,060

1,382

(1,456)

152

Taxation

 

(677)

Loss for the period

 

(525)

 

  

 

Year ended

Insight

Communications

Health

Head office

Group

31 March 2010

£'000

£'000

£'000

£'000

£'000

Turnover (billings)

27,839

54,989

10,845

-

93,673

Revenue

15,956

36,457

8,846

-

61,259

Headline PBIT

4,883

5,455

2,711

(2,237)

10,812

Restructuring costs

(354)

(230)

-

-

(584)

Goodwill write-off

(3,786)

-

-

-

(3,786)

Future acquisition payments to employees deemed as remuneration

 

 

 

(36)

 

 

 

(215)

 

 

 

(5)

 

 

 

(261)

 

 

 

(517)

Reported PBIT

707

5,010

2,706

(2,498)

5,925

Finance income

-

-

-

6

6

Finance costs

-

-

-

(676)

(676)

Notional finance cost on future deferred consideration

 

 

(204)

 

 

(193)

 

 

(7)

 

 

-

 

 

(404)

Income from financial assets

 

 

-

 

 

195

 

 

195

-

-

Profit before taxation

503

5,012

2,699

(3,168)

5,046

Taxation

 

(2,128)

Profit for the period

 

2,918

 

 

Geographical segmentation

 

The following table provides an analysis of the Group's turnover and revenue by geographical market, irrespective of the origin of the services.

 

Revenue

Turnover

Six months ended 30 September 2010

Six months ended 30 September 2009

Year ended 31 March 2010

Six months ended 30 September 2010

Six months ended 30 September 2009

Year ended 31 March 2010

£'000

£'000

£'000

£'000

£'000

£'000

UK

25,250

23,134

47,563

37,354

35,670

74,916

Rest of Europe

6,001

4,687

11,682

7,472

7,545

15,941

Rest of the World

 

760

 

1,673

 

2,014

 

1,061

 

1,927

 

2,816

 

32,011

 

29,494

 

61,259

 

45,887

 

45,142

 

93,673

 

 

6. Taxation

 

The effective Reported tax rate including discontinued operations for the period ended 30 September 2010 is 115% (the effective Reported tax rate for the period ended 30 September 2009 was 70%). The rate for this period is high due to the loss on disposal of DLKW on which no tax relief is available.

 

 The effective Reported rate in respect of the continuing operations for the period ended 30 September 2010 is 28%, in line with the current statutory rate of 28%.

 

The effective Headline tax rate for the six months ended 30 September 2010 is 28% (the effective Headline tax rate for the six months ended 30 September 2009 was 24%). This rate is in line with the current statutory corporation tax rate of 28%.

 

7. Discontinued Operations

 

(a) Description

 

On 28 June 2010, the Group announced the proposed sale of Delaney Lund Knox Warren and Partners, Dialogue DLKW and The Composing Room ('DLKW') for £28.0 million, which was then approved by shareholders on 13 July 2010 with effect from 14 July 2010. DLKW is reported in the financial statements for the half-year ended 30 September 2010 as a discontinued operation.

 

(b) Financial performance

 

The financial performance information for the half year to 30 September 2010 below shows the results of DLKW until the effective date of disposal (14 July 2010). The period to 30 September 2009 and 31 March 2010 show the financial information of DLKW for the full six months and full year respectively.

 

Six months ended

30 September 2010

£'000

Six months ended

30 September 2009

£'000

Year ended

31 March

 2010

£'000

Turnover (billings)

9,180

17,652

43,149

Revenue

4,472

9,187

19,241

Headline operating costs

(4,307)

(7,691)

(15,796)

Headline PBIT

165

1,496

3,445

Loss on disposal (section (e))

(3,459)

-

-

Restructuring costs

-

(177)

(338)

Reported (loss)/profit before interest and tax

 

(3,294)

 

1,319

 

3,107

Reported (loss)/profit before tax

 

(3,294)

 

1,319

 

3,107

Taxation

135

(359)

(892)

(Loss)/profit for the period

(3,159)

960

2,215

 

(c) Cash flow information

 

Refer to the statement of cashflows for the amounts related to discontinued operations.

 

(d) Carrying amounts of assets and liabilities

 

The carrying amounts of assets and liabilities as at 14 July 2010 were:

 

As at

14 July 2010

£'000

Property, plant and equipment

350

Trade receivables

5,919

Inventories and work in progress

471

Deferred tax asset

219

Cash and short term deposits

1,331

Total assets

8,290

Trade and other payables

(8,200)

Corporation tax payable

(40)

Total liabilities

(8,240)

Net assets

50

 

(e) Financial information on the sale of DLKW

 

£'000

Proceeds from the sale

28,000

Costs associated with the sale

(626)

Goodwill write-off

(30,533)

Intangible asset write-off

(250)

Carrying amount of net assets sold

(50)

Loss on disposal of subsidiary

(3,459)

 

The subsidiary disposed of (DLKW) was reportable under the Communications division.

 

8. Earnings per share

 

Headline

Reported

Six months ended 30 September 2010

£'000

Six months ended 30 September 2009

£'000

Year ended 31 March 2010

£'000

Six months ended 30 September 2010

 £'000

Six months ended 30 September 2009

£'000

Year ended 31 March 2010

£'000

Earnings

 

 

Profit/(loss) for the period from continuing operations

 

 

 

 

3,053

 

 

 

 

3,692

 

 

 

 

7,912

 

 

 

 

3,026

 

 

 

 

(525)

 

 

 

 

2,918

Profit/(loss) from discontinued operations

 

 

 

125

 

 

 

1,087

 

 

 

2,458

 

 

 

(3,159)

 

 

 

960

 

 

 

2,215

 

3,178

 

4,779

 

10,370

 

(133)

 

435

 

5,133

Number of shares

Weighted average number of shares

 

60,285,576

 

56,898,349

 

58,729,868

 

60,285,576

 

56,898,349

 

58,729,868

Dilutive effect of shares

 

-

 

-

 

32,047

 

-

 

-

 

32,047

 

60,285,576

 

56,898,349

 

58,761,915

 

60,285,576

 

56,898,349

 

58,761,915

Earnings per share

Basic earnings/

(loss) per share (pence):

 - continuing operations

 

5.06

 

6.49

 

13.47

 

5.02

 

(0.92)

 

4.98

- discontinued operations

 

0.21

 

1.91

 

4.19

 

(5.24)

 

1.68

 

3.77

 

5.27

 

8.40

 

17.66

 

(0.22)

 

0.76

 

8.75

Diluted earnings/(loss) per share pence:

 - continuing operations

 

5.06

 

6.49

 

13.46

 

5.02

 

(0.92)

 

4.97

- Discontinued operations

 

0.21

 

1.91

 

4.19

 

(5.24)

 

1.68

 

3.77

 

5.27

 

8.40

 

17.65

 

(0.22)

 

0.76

 

8.74

 

Diluted earnings per share (DEPS) has been calculated based on the following dilutive element:

 

For 31 March 2010 there were 32,047 restricted shares that had vested but not been issued at the balance sheet date.

 

The Headline EPS and Headline DEPS are based on the Headline PBT analysed in note 4 less attributable tax and divided by the weighted average number of shares and by the weighted average number of diluted shares, respectively.

 

9. Dividends

 

The prior year final dividend of 1.00 pence per share (H1 2010: nil pence per share) was paid to shareholders on 8 September 2010 giving a total of £603,000 (H1 2010: nil).

 

The Board has declared an interim dividend to be paid on 10 January 2011 of 0.75 pence (H1 2010: nil pence) per share to all ordinary shareholders on the register at 10 December 2010.

 

10. Non-current assets

 

Six months ended 30 September 2010

Property, plant and equipment

Intangible assets - goodwill

Intangible assets - other

£'000

£'000

£'000

Net book amount at 1 April 2010

2,065

119,081

1,551

Additions - continuing group

532

-

81

Additions - discontinued operations

44

-

-

Disposal of DLKW

(350)

(30,533)

(250)

Depreciation and amortisation - continuing group

(461)

-

(234)

Depreciation and amortisation - discontinued operations

(76)

-

-

Net book amount at 30 September 2010

1,754

88,548

1,148

Six months ended 30 September 2009

Property, plant and equipment

Intangible assets - goodwill

Intangible assets - other

£'000

£'000

£'000

Net book amount at 1 April 2009

2,514

122,856

1,582

Additions - continuing group

558

-

123

Additions - discontinued operations

96

-

-

Disposals

(19)

-

-

Transfer from tangibles/ to intangibles

(65)

-

65

Write-off of goodwill

-

(3,786)

-

Adjustments to consideration

-

11

-

Depreciation and amortisation - continuing group

(513)

-

(151)

Depreciation and amortisation - discontinued operations

(170)

-

-

Net book amount at 30 September 2009

 

2,401

119,081

1,619

 

 

 

 

 

 

Year ended 31 March 2010

Property, plant and equipment

Intangible assets - goodwill

Intangible assets - other

£'000

£'000

£'000

Net book amount at 1 April 2009

2,514

122,856

1,582

Transfer to intangibles

(65)

65

Additions - continuing group

848

-

227

Additions - discontinued operations

155

-

-

Disposals

(11)

-

-

Adjustments to consideration

-

11

-

Depreciation and amortisation - continuing group

(1,019)

-

(323)

Depreciation and amortisation - discontinued operations

(357)

-

-

Fair value adjustment

-

(3,786)

-

At 31 March 2010

 

2,065

119,081

1,551

 

 

11. Derivative financial instrument

 

The derivative financial instrument matured in August 2010. For the prior periods, however, the instrument had been calculated by assessing the movement in fair value of the forward contract. This contract qualified for hedge accounting and was treated as a cashflow hedge, and therefore the effective portion of the change in fair value was recognised within the statement of comprehensive income. The ineffective portion was recognised directly in the income statement. By 30 September 2010 the hedge had been settled and there was no outstanding liability.

 

12. Reconciliation of profit for the period to operating cash flow

 

Six months

ended

30 September

2010

 

£'000

Six months

ended

30 September

2009

 

£'000

Year

Ended

31 March

2010

 

£'000

Profit/(loss) for the period

3,026

(525)

2,918

Taxation

1,170

677

2,128

Profit before taxation

4,196

152

5,046

Income from financial assets

-

-

(195)

Finance costs

212

455

1,080

Finance income

(1)

(1)

(6)

Profit before finance income, finance costs, income from financial assets and taxation

 

 

4,407

 

 

606

 

 

5,925

Depreciation of property, plant and equipment

 

461

 

513

 

1,019

Amortisation of intangible assets

234

151

323

Share based payments

5

(123)

(92)

Deemed remuneration

38

254

517

Goodwill write-off

-

3,786

3,786

Loss/(profit) on disposal of property, plant and equipment

 

-

 

3

 

(1)

Increase in inventories and work in progress

 

(260)

 

(641)

 

(719)

Decrease/(increase) in trade and other receivables

 

1,187

 

(1,025)

 

(3,293)

(Decrease)/increase in trade and other payables

 

(4,203)

 

593

 

6,221

 

Operating cash flow

 

1,869

 

4,117

 

13,686

 

 

13. Analysis of net and total debt

 

Six months ended

30 September 2010

 

As at

1 April

2010

 

£'000

Cash flow

 

 

 

£'000

As at

30 September 2010

 

£'000

Cash and short term deposits

 

2,778

 

(2,546)

 

232

Bank overdrafts and

revolving credit facility

 

(13,000)

 

13,000

 

-

Acquisition loan notes

(3,087)

3,057

(30)

Bank loans

(11,600)

11,600

-

Finance leases

(16)

1

(15)

Net and total (debt)/cash

(24,925)

25,112

187

 

 

Six months ended

30 September 2009

 

 

 

As at

1 April

2009

 

£'000

Other movements

 

£'000

Acquisitions

 

 

£'000

Cash flow

 

 

£'000

As at

30 September 2009

£'000

Cash and short term deposits

 

2,806

 

-

 

-

 

(2,804)

 

2

Bank overdrafts and

revolving credit facility

 

 

(7,000)

 

 

-

 

 

-

 

 

5,000

 

 

(2,000)

Acquisition loan notes

 

(23)

 

-

 

(19,680)

 

8

 

(19,695)

Bank loans

(14,400)

-

-

1,400

(13,000)

Finance leases

(8)

-

-

4

(4)

Net (debt)

(18,625)

-

(19,680)

3,608

(34,697)

Restricted cash deposits

 

22

 

-

 

-

 

(8)

 

14

Net (debt) including restricted cash deposits

 

 

(18,603)

 

 

-

 

 

(19,680)

 

 

3,600

 

 

(34,683)

Provision for deferred consideration

 

 

(22,300)

 

 

(820)

 

 

19,680

 

 

3,440

 

 

-

Total debt

(40,903)

(820)

-

7,040

(34,683)

 

 

Year ended

31 March 2010

 

 

 

As at

1 April

2009

 

£'000

Other movements

 

£'000

Acquisitions

 

 

£'000

Cash flow

 

 

£'000

As at

31 March 2010

 

£'000

Cash and short term deposits

 

2,806

 

-

 

-

 

(28)

 

2,778

Bank overdrafts and

revolving credit facility

 

 

(7,000)

 

 

-

 

 

-

 

 

(6,000)

 

 

(13,000)

Acquisition loan notes

 

(23)

 

-

 

(19,682)

 

16,618

 

(3,087)

Bank loans

(14,400)

-

-

2,800

(11,600)

Finance leases

(8)

-

-

(8)

(16)

Net (debt)

(18,625)

-

(19,682)

13,382

(24,925)

Restricted cash deposits

 

22

 

-

 

-

 

(22)

 

-

Net (debt) including restricted cash deposits

 

 

(18,603)

 

 

-

 

 

(19,682)

 

 

13,360

 

 

(24,925)

Provision for deferred consideration

 

 

(22,300)

 

 

(822)

 

 

19,682

 

 

3,440

 

 

-

Total debt

(40,903)

(822)

-

16,800

(24,925)

 

  

The bank overdrafts, revolving credit facility, acquisition loan notes and bank loans are as follows:

 

 

 

 

 

 

Current

Non-current

 

30 September

2010

£'000

 

30

-

 

30 September

2009

£'000

 

24,695

10,000

 

31 March

2010

£'000

 

27,687

-

30

34,695

27,687

 

 

14. Related-party transactions

 

During the six months ended 30 September 2010 total fees of £29,245 (H1 2010: £29,082) were paid to City Group P.L.C. £14,245 (H1 2010: £14,082) for the provision of secretarial services and £15,000 (H1 2010: £15,000) for the services of Mr D C Marshall, a non-executive director.

 

15. Key risks and uncertainties

 

As detailed on page 32 of the 2010 Annual Report and Accounts, the Group's key risks and uncertainties are associated with the retention of key personnel and customers. These risks are not considered to have changed since the 2010 Annual Report and Accounts were published, however due to the fluctuations in the euro exchange rate and Creston having a contractual obligation to bill certain clients in euros, the Board decided to enter into a participating forward contract on 1 October 2010 for €4.5 million maturing on 31 March 2011.

 

16. Post balance sheet events

 

Today we announced the proposed acquisition of Cooney/Waters, a healthcare public relations business based in the United States of America for an initial cash consideration of $9.4 million (£5.9 million) payable on completion. There is also an additional earn-out consideration of up to a maximum of $21.4 million (£13.5 million) based upon certain performance criteria. This acquisition will be recommended to shareholders at the General Meeting on 15 December 2010 for their approval. Details of the financial information surrounding the transaction can be found in a separate circular.

 

17. Statement of directors' responsibilities

 

The Directors' confirm that to the best of their knowledge these condensed consolidated set of financial statements have been prepared in accordance with IAS 34 as adopted by the European Union. The interim management report includes a fair review of the information required by DTR 4.2.7R and DTR 4.2.8R; namely:

 

·; an indication of important events that have occurred during the first six months and their impact on the condensed set of financial statements, and a description of the principal risks and uncertainties for the remaining six months of the financial year; and

 

·; material related-party transactions in the first six months and any material changes in the related party transactions described in the last annual report.

 

The Directors are responsible for the maintenance and integrity of the Company website. Legislation in the United Kingdom governing the preparation and dissemination of financial statements may differ from legislation in other jurisdictions.

 

The Directors of Creston plc are listed in the Creston Group Annual Report and Accounts 2010. A list of current directors is maintained on the Creston website: www.creston.com.

 

By order of the Board

Don Elgie

30 November 2010

Chief Executive Officer

 

18. Forward-looking statements

 

Certain statements in this interim report are forward-looking. Although the Group believes that the expectations reflected in these forward-looking statements are reasonable, we can give no assurance that these expectations will prove to have been correct. Because these statements involve risks and uncertainties, actual results may differ materially from those expressed or implied by these forward-looking statements.

 

We undertake no obligation to update any forward-looking statements whether as a result of new information, future events or otherwise.

 

 

19. Availability of the Interim Report

 

Copies of the Interim Report are available from the Company's registered office at City Group P.L.C., 30 City Road, London, EC1Y 2AG and on the company's website www.creston.com.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IR BIBDBDDDBGGC
Date   Source Headline
25th Apr 20244:11 pmRNSHolding(s) in Company
19th Apr 20247:00 amRNSHolding(s) in Company
18th Apr 20247:00 amRNSHolding(s) in Company
12th Apr 20247:00 amRNSNotice of AGM
12th Apr 20247:00 amRNSDirector/PDMR Shareholding
8th Apr 20244:34 pmRNSDirector/PDMR Shareholding
4th Apr 20243:52 pmRNSDirector/PDMR Shareholding
28th Mar 20243:53 pmRNSDirector/PDMR Shareholding
27th Mar 20247:00 amRNSDirector/PDMR Shareholding
25th Mar 20244:49 pmRNSDirector/PDMR Shareholding
25th Mar 20244:49 pmRNSDirector/PDMR Shareholding
25th Mar 20244:48 pmRNSDirector/PDMR Shareholding
25th Mar 20244:48 pmRNSDirector/PDMR Shareholding
12th Mar 20243:11 pmRNSHolding(s) in Company
7th Mar 20245:52 pmRNSPurchase of Shares by Employee Benefit Trust
6th Mar 20243:53 pmRNSPurchase of Shares by Employee Benefit Trust
6th Mar 20247:00 amRNSHolding(s) in Company
5th Mar 20244:48 pmRNSPurchase of Shares by Employee Benefit Trust
4th Mar 20243:58 pmRNSPurchase of Shares by Employee Benefit Trust
1st Mar 20244:00 pmRNSPurchase of Shares by Employee Benefit Trust
28th Feb 20241:40 pmRNSAnnual Financial Report
28th Feb 20247:00 amRNSPurchase of Shares by Employee Benefit Trust
28th Feb 20247:00 amRNSHolding(s) in Company
26th Feb 20245:44 pmRNSPurchase of Shares by Employee Benefit Trust
26th Feb 20247:00 amRNSPurchase of Shares by Employee Benefit Trust
21st Feb 20247:00 amRNSAppointment of Senior Independent Director
21st Feb 20247:00 amRNSPreliminary results for the year ended 31/12/2023
13th Feb 20247:00 amRNSNotice of Full Year 2023 Trading Update
29th Jan 20247:00 amRNSPerformance Update
25th Jan 20247:00 amRNSJanuary 2024 Trading Update
15th Jan 20247:00 amRNSNotice of 1 January 2024 Renewals Trading Update
14th Dec 20235:39 pmRNSDirector/PDMR Shareholding
8th Dec 20233:45 pmRNSPurchase of Shares by Employee Benefit Trust
7th Dec 20232:22 pmRNSPurchase of Shares by Employee Benefit Trust
6th Dec 20232:52 pmRNSPurchase of Shares by Employee Benefit Trust
6th Dec 20237:00 amRNSPurchase of Shares by Employee Benefit Trust
5th Dec 20233:46 pmRNSPurchase of Shares by Employee Benefit Trust
1st Dec 20235:28 pmRNSPurchase of Shares by Employee Benefit Trust
30th Nov 20233:28 pmRNSPurchase of Shares by Employee Benefit Trust
29th Nov 20233:51 pmRNSPurchase of Shares by Employee Benefit Trust
29th Nov 20237:00 amRNSHolding(s) in Company
28th Nov 20234:41 pmRNSPurchase of Shares by Employee Benefit Trust
27th Nov 20233:17 pmRNSPurchase of Shares by Employee Benefit Trust
24th Nov 20232:02 pmRNSPurchase of Shares by Employee Benefit Trust
23rd Nov 20234:25 pmRNSPurchase of Shares by Employee Benefit Trust
22nd Nov 20235:06 pmRNSPurchase of Shares by Employee Benefit Trust
17th Nov 20234:20 pmRNSPurchase of Shares by Employee Benefit Trust
8th Nov 20237:00 amRNSDirectorate Change
8th Nov 20237:00 amRNSThird Quarter 2023 Trading Update
26th Oct 20237:00 amRNSNotice of Q3 2023 Trading Update and Webcast

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.